A citation-based method for searching scientific literature


List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence.
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini. Diabetes Metab Syndr Obes 2020
19
75

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
75

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
75

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes.
María Isabel Del Olmo-Garcia, Juan Francisco Merino-Torres. J Diabetes Res 2018
26
50


GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Andrei C Sposito, Otávio Berwanger, Luiz Sérgio F de Carvalho, José Francisco Kerr Saraiva. Cardiovasc Diabetol 2018
38
50

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Ming Yu, Carol Moreno, Kimberly M Hoagland, Annette Dahly, Katie Ditter, Mahesh Mistry, Richard J Roman. J Hypertens 2003
198
50

Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan. Clin Ther 2015
77
50

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan. Diabetes Res Clin Pract 2015
114
50

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
946
50

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.
John B Buse, Daniel J Drucker, Kristin L Taylor, Terri Kim, Brandon Walsh, Hao Hu, Ken Wilhelm, Michael Trautmann, Larry Z Shen, Lisa E Porter. Diabetes Care 2010
223
50


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll. PLoS One 2016
88
50

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans-Juergen Woerle, Maximilian von Eynatten, Uli C Broedl. Cardiovasc Diabetol 2014
259
50


Including known covariates can reduce power to detect genetic effects in case-control studies.
Matti Pirinen, Peter Donnelly, Chris C A Spencer. Nat Genet 2012
54
25

Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.
Robert Martinez, Hussein Al-Jobori, Ali M Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A DeFronzo, Eugenio Cersosimo. Diabetes 2018
25
25


The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients.
Marko Skelin, Eugen Javor, Marko Lucijanić, Tomo Lucijanić, Lejsa Jakupović, Dario Rahelić. Int J Clin Pract 2018
4
25


Genomic atlas of the human plasma proteome.
Benjamin B Sun, Joseph C Maranville, James E Peters, David Stacey, James R Staley, James Blackshaw, Stephen Burgess, Tao Jiang, Ellie Paige, Praveen Surendran,[...]. Nature 2018
232
25

Interpreting findings from Mendelian randomization using the MR-Egger method.
Stephen Burgess, Simon G Thompson. Eur J Epidemiol 2017
186
25

The New Biology and Pharmacology of Glucagon.
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
97
25

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
840
25

Genetic determinants of circulating GIP and GLP-1 concentrations.
Peter Almgren, Andreas Lindqvist, Ulrika Krus, Liisa Hakaste, Emilia Ottosson-Laakso, Olof Asplund, Emily Sonestedt, Rashmi B Prasad, Esa Laurila, Marju Orho-Melander,[...]. JCI Insight 2017
18
25

The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes.
Sofie Hædersdal, Asger Lund, Filip K Knop, Tina Vilsbøll. Mayo Clin Proc 2018
26
25

Hemodynamic Effects of Glucagon: A Literature Review.
Kasper Meidahl Petersen, Søren Bøgevig, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen. J Clin Endocrinol Metab 2018
11
25

The glucagon receptor is required for the adaptive metabolic response to fasting.
Christine Longuet, Elaine M Sinclair, Adriano Maida, Laurie L Baggio, Marlena Maziarz, Maureen J Charron, Daniel J Drucker. Cell Metab 2008
131
25

Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
Yiqiang Zhan, Ida K Karlsson, Robert Karlsson, Annika Tillander, Chandra A Reynolds, Nancy L Pedersen, Sara Hägg. Circ Res 2017
43
25



Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.
Eleanor Wheeler, Aaron Leong, Ching-Ti Liu, Marie-France Hivert, Rona J Strawbridge, Clara Podmore, Man Li, Jie Yao, Xueling Sim, Jaeyoung Hong,[...]. PLoS Med 2017
137
25

Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
Salim S Virani, Alvaro Alonso, Emelia J Benjamin, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Francesca N Delling,[...]. Circulation 2020
583
25

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure.
Chen Gao, Shuxun Vincent Ren, Junyi Yu, Ulysis Baal, Dung Thai, John Lu, Chunyu Zeng, Hai Yan, Yibin Wang. JACC Basic Transl Sci 2019
3
33

Metabolic effects of glucagon in humans.
María M Adeva-Andany, Raquel Funcasta-Calderón, Carlos Fernández-Fernández, Elvira Castro-Quintela, Natalia Carneiro-Freire. J Clin Transl Endocrinol 2018
13
25


The MR-Base platform supports systematic causal inference across the human phenome.
Gibran Hemani, Jie Zheng, Benjamin Elsworth, Kaitlin H Wade, Valeriia Haberland, Denis Baird, Charles Laurin, Stephen Burgess, Jack Bowden, Ryan Langdon,[...]. Elife 2018
477
25


Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
Jack Bowden, Fabiola Del Greco M, Cosetta Minelli, George Davey Smith, Nuala A Sheehan, John R Thompson. Int J Epidemiol 2016
203
25

Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses.
Tom M Palmer, Jonathan A C Sterne, Roger M Harbord, Debbie A Lawlor, Nuala A Sheehan, Sha Meng, Raquel Granell, George Davey Smith, Vanessa Didelez. Am J Epidemiol 2011
141
25

Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
C Mary Schooling, Shan Luo, Shiu Lun Au Yeung, Deborah J Thompson, Savita Karthikeyan, Thomas R Bolton, Amy M Mason, Erik Ingelsson, Stephen Burgess. Int J Cardiol 2018
18
25

Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus.
Mohamed Lotfy, Huba Kalasz, Gyorgy Szalai, Jaipaul Singh, Ernest Adeghate. Open Med Chem J 2014
11
25

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R Robertson, Jason M Torres, N William Rayner, Anthony J Payne, Valgerdur Steinthorsdottir, Robert A Scott, Niels Grarup,[...]. Nat Genet 2018
309
25

Association analyses based on false discovery rate implicate new loci for coronary artery disease.
Christopher P Nelson, Anuj Goel, Adam S Butterworth, Stavroula Kanoni, Tom R Webb, Eirini Marouli, Lingyao Zeng, Ioanna Ntalla, Florence Y Lai, Jemma C Hopewell,[...]. Nat Genet 2017
212
25

Glucagon increases contractility in ventricle but not in atrium of the rat heart.
Carmen Gonzalez-Muñoz, Susana Nieto-Cerón, Juan Cabezas-Herrera, Jesús Hernández-Cascales. Eur J Pharmacol 2008
23
25

Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.
Stephen Burgess, Robert A Scott, Nicholas J Timpson, George Davey Smith, Simon G Thompson. Eur J Epidemiol 2015
248
25

Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.
Wei Zhou, Jonas B Nielsen, Lars G Fritsche, Rounak Dey, Maiken E Gabrielsen, Brooke N Wolford, Jonathon LeFaive, Peter VandeHaar, Sarah A Gagliano, Aliya Gifford,[...]. Nat Genet 2018
114
25

Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Qutuba G Karwi, Liyan Zhang, Cory S Wagg, Wang Wang, Manoj Ghandi, Dung Thai, Hai Yan, John R Ussher, Gavin Y Oudit, Gary D Lopaschuk. Cardiovasc Diabetol 2019
20
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.